Work

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Year: 2016

Type: article

Source: Journal of Hepatology

DOI: 10.1016/j.jhep.2016.01.029

Authors: Graham R. Foster, William L. Irving, Michelle C.M. Cheung, Alex J. Walker, Benjamin E. Hudson, Suman Verma, John McLauchlan, David J. Mutimer, Ashley Brown, William T.H. Gelson, Douglas C. MacDonald, Kosh Agarwal

Institutions: Queen Mary University of London, NIHR Nottingham Digestive Diseases Biomedical Research Unit, Blizard Institute, University of Nottingham, University Hospitals Bristol NHS Foundation Trust, King's College London, MRC University of Glasgow Centre for Virus Research, Queen Elizabeth Hospital Birmingham, NIHR Birmingham Liver Biomedical Research Unit, St Mary's Hospital, Imperial College London, Cambridge University Hospitals NHS Foundation Trust, University College London

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Heart of England NHS Foundation Trust, National Institute for Health and Care Research, Gilead UK and Ireland Corporate Contributions, Medical Research Council, Medical Research Foundation

Awards: Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection, Viral Hepatitis, Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer, Optimising the clinical and cost effectiveness of therapy for chronic hepatitis C virus infection. Strategies to identify patients who require modified treatment regimes., Immunity in the face of diversity and the development of novel potent HCV vaccines

OpenAlex ID: W2325297898

FWCI: 52.04

Cites: 15

Cited by: 494

Related to: 10